Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleEfficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.AuthorsSulkowski, M. S.; Feld, J. J.; Lawitz, E.; Felizarta, F.; Corregidor, A. M.; Khalid, O.; Ghalib, R.; Smith, W. B.; Van Eygen, V.; Luo, D.; Vijgen, L.; Gamil, M.; Kakuda, T. N.; Ouwerkerk‐Mahadevan, S.; Van Remoortere, P.; Beumont, M.PublicationJournal of Viral Hepatitis, 2018, Vol 25, Issue 6, p631ISSN1352-0504Publication typeArticleDOI10.1111/jvh.12853